Understanding the Basics of Study Design
A promising research question can still produce inconclusive results if the population, intervention, comparator, endpoints, and analysis approach don’t fit
A promising research question can still produce inconclusive results if the population, intervention, comparator, endpoints, and analysis approach don’t fit
What is clinical trial study design? Clinical trial study design turns a research question into a structured, ethical, and executable
Adaptive study designs are best suited for oncology clinical trials when meaningful uncertainty exists and a protocol can prospectively use
Investigator-initiated trials (IITs) play a critical role in advancing clinical research by allowing investigators to pursue important scientific questions beyond
When it comes to unnecessary protocol complexity, the cracks often show up later. Amendments. Delayed activation. Added site burden. By
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger
Key takeaways from ‘The Operational Realities of Protocol Amendments’ panel discussion at the Advarra Innovation Summit in Research Triangle Park
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Oncology research continues to push scientific boundaries, from biomarker-driven therapies to increasingly personalized treatment strategies. Operationally, however, many oncology trials
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.